TP53 and breast carcinoma: Shaban et al. [198] highlighted that miR-34 and miR-21 can predict the response of breast cancer patients to chemo-radiotherapy, especially by regulating Bcl-2, BRCA1, BRCA2, and p53 targets in breast cancer cells.